Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $136.99 USD
Change Today +1.99 / 1.47%
Volume 2.2M
As of 8:10 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter R. Mueller Ph.D.

Former Chief Scientific Officer, Executive Vice President of Global Research & Development and Member of The Scientific Advisory Board, Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 4 different industries.

See Board Relationships
58--
As of Fiscal Year 2013

Background*

Dr. Peter R. Mueller, Ph.D. has been Chief Scientific Officer and President of Research & Development at Pronutria, Inc. since December 4, 2014. Dr. Mueller served a the Chief Scientific Officer at Vertex Pharmaceuticals Incorporated from July 21, 2003 to October 2014 and Executive Vice President of Global Research & Development from May 2009 to October 2014. Dr. Mueller was responsible for research and drug discovery activities and directs research strategy across the ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

Director

Education*

PhD
Albert Einstein University of Ulm Germany
Bachelor's Degree
Albert Einstein University of Ulm Germany
PhD
University of Mainz, Germany

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $136.99 USD +1.99

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.